• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

PLoS ONE. A Combination of Serological Assays to Detect Human Antibodies to the Avian Influenza A H7N9 Virus

Giuseppe

Emeritus
[Source: PLoS ONE, full page: (LINK). Abstract, edited.]


Open Access / Peer-Reviewed / Research Article

A Combination of Serological Assays to Detect Human Antibodies to the Avian Influenza A H7N9 Virus

Libo Dong, Hong Bo, Tian Bai, Rongbao Gao, Jie Dong, Ye Zhang, Junfeng Guo, Shumei Zou, Jianfang Zhou, Yun Zhu, Li Xin, Xiaodan Li, Cuiling Xu, [ ... ], Dayan Wang, Yuelong Shu

Published: April 22, 2014 / DOI: 10.1371/journal.pone.0095612


Abstract

Human infection with avian influenza A H7N9 virus was first identified in March 2013 and represents an ongoing threat to public health. There is a need to optimize serological methods for this new influenza virus. Here, we compared the sensitivity and specificity of the hemagglutinin inhibition (HI), microneutralization (MN), and Western blot (WB) assays for the detection of human antibodies against avian influenza A (H7N9) virus. HI with horse erythrocytes (hRBCs) and a modified MN assay possessed greater sensitivity than turkey erythrocytes and the standard MN assay, respectively. Using these assays, 80% of tested sera from confirmed H7N9 cases developed detectable antibody to H7N9 after 21 days. To balance sensitivity and specificity, we found serum titers of ≥20 (MN) or 160 (HI) samples were most effective in determining seropositive to H7N9 virus. Single serum with HI titers of 20?80 or MN titer of 10 could be validated by each other or WB assay. Unlike serum collected from adult or elderly populations, the antibody response in children with mild disease was low or undetectable. These combinations of assays will be useful in case diagnosis and serologic investigation of human cases.
_____

Citation: Dong L, Bo H, Bai T, Gao R, Dong J, et al. (2014) A Combination of Serological Assays to Detect Human Antibodies to the Avian Influenza A H7N9 Virus. PLoS ONE 9(4): e95612. doi:10.1371/journal.pone.0095612

Editor: Zhiping Ye, Center for Biologics Evaluation and Research, United States of America

Received: November 4, 2013; Accepted: March 27, 2014; Published: April 22, 2014

Copyright: ? 2014 Dong et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Funding: This study was supported by the National Basic Research Program (973) of China (2011CB504704, to Dr. Shu); the Emergency Research Project on human infection with avian influenza H7N9 virus from the National Ministry of Science and Technology (No. KJYJ-2013-01-01 to Dr. Shu); and National Mega-projects for Infectious Diseases (2012ZX10004501-004-002 to Dr. Dong). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

Competing interests: The authors have declared that no competing interests exist.


-
------
 
Back
Top Bottom